Jefferies Raises Revenue Expectations for Complete Genomics
April 18, 2011
Jefferies Raises Revenue Expectations for Complete Genomics
Jefferies analyst Jon Wood also raised his price target on the firm's stock to $15.50 from $13, following a presentation by Complete Genomics CEO Clifford Reid at a biotech conference.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.